St. Joseph, MO, United States of America

Merrill Lynn Schaeffer

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 4.2

ph-index = 12

Forward Citations = 358(Granted Patents)


Location History:

  • Saint Joseph, MO (US) (2010 - 2017)
  • Ridgefield, CT (US) (2018)
  • St. Joseph, MO (US) (2010 - 2023)

Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Merrill Lynn Schaeffer

Introduction: Merrill Lynn Schaeffer is a notable inventor based in St. Joseph, MO, who has made significant contributions to the field of veterinary medicine. With an impressive portfolio of 23 patents, Schaeffer’s work primarily focuses on developing innovative solutions for protecting livestock from viral diseases.

Latest Patents: Among his latest patents, Schaeffer has been instrumental in the development of vaccines against porcine parvovirus and porcine reproductive and respiratory syndrome virus. One patent describes methods of manufacturing an immunogenic composition comprising a recombinant protein to protect swine against these diseases. Additionally, he has patented methods for quantifying vaccine compositions, which provide new approaches for detecting viral proteins through mass-spectroscopic analyses, particularly in the context of porcine circovirus vaccines.

Career Highlights: Merrill Lynn Schaeffer has had a distinguished career working at Boehringer Ingelheim Vetmedica GmbH, where he applied his expertise in the field of veterinary medicine. Throughout his career, he has focused on creating advanced immunogenic compositions that enhance the health and safety of swine populations.

Collaborations: Schaeffer has collaborated with esteemed colleagues such as Marc Allan Eichmeyer and Michael B. Roof, further enriching his contributions to the sector. These collaborations have been vital in advancing the development of his innovative vaccines and ensuring their effectiveness in combating viral diseases in livestock.

Conclusion: Merrill Lynn Schaeffer’s work exemplifies the critical role of innovation in veterinary medicine. His extensive patent portfolio and collaborative efforts highlight his commitment to improving animal health, reflecting the importance of creating effective solutions for agricultural industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…